4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-19-003604
President and CEO sold 15,000 shares at an average $52.54 ($788,088)
- President and CEO acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mills Kenneth T. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-19 | Exercise or conversion : show line 1 in the form | +15,000 | $0.85 | $12,750 | 261,000 | D |
| 2019-06-19 | Sale : show line 2 in the form | −10,880 | $52.27 | $568,698 | 250,120 | D |
| 2019-06-19 | Sale : show line 3 in the form | −4,120 | $53.25 | $219,390 | 246,000 | D |
| Open-market sales · 15,000 sh · avg $52.54 · $788,088 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-06-19 | Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) | −15,000 | $0.85 | 2024-09-23 | 15,000 | 114,670 | D |
Loading xslF345X03/primarydocument.xml…